FeatureID,Name,Formula,MW,KEGG Pathways,name4plot,C,H,N,O,S,P,Cl,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,gap_status,control_means,treatment_means,log2FC,pval,pval.adj,Comment
Feature0366,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Missing ions,24.051229588371072,12.02324355555253,-12.027986032818543,0.0158194584093287,0.04291448823807254,Downregulated
Feature0357,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,No gap,0,0,0,NA,NA,NA
Feature0352,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid-peak4,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,26.53762496104956,0,-26.53762496104956,1.2782400042409932e-9,1.8282987634285166e-8,Downregulated
Feature0351,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid-peak3,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,23.96398441376752,0,-23.96398441376752,1.6754628320194544e-7,1.7801792590206703e-6,Downregulated
Feature0350,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid-peak2,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,8.946346578724654,0,-8.946346578724654,0.019190438426273233,0.04845110691781856,Downregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0343,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone-peak1,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,20.754974668798187,0,-20.754974668798187,2.9554971177433675e-6,1.8421227688132717e-5,Downregulated
Feature0339,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol-peak1,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0337,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,26.351822168891452,26.28656722290515,-0.06525494598630388,0.6614936279569958,0.6856946143456665,Downregulated
Feature0335,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,No gap,29.37240283899076,27.734157483070735,-1.6382453559200236,5.064051578083366e-7,4.452872939349166e-6,Downregulated
Feature0333,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0312,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,26.819170947442952,26.784929060294285,-0.03424188714866716,0.8121680791058123,0.8317383942649886,Downregulated
Feature0311,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0303,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0300,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,26.68990410734011,1.8242681353017929,-24.865635972038316,4.285108242937243e-9,5.7510663260473523e-8,Downregulated
Feature0295,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,19.092082179037547,1.8864503683160356,-17.20563181072151,8.322548371796547e-5,4.613586597408955e-4,Downregulated
Feature0276,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate-peak2",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,18.65985795900038,28.830822301191716,10.170964342191336,0.012032196784421688,0.03409122422252812,Upregulated
Feature0274,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0249,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,No gap,0,0,0,NA,NA,NA
Feature0245,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine-peak3,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0240,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,28.839470547449853,0,-28.839470547449853,5.854452680440954e-26,2.1326934764463476e-24,Downregulated
Feature0239,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,29.9580426174352,29.395689517653327,-0.5623530997818733,0.01037929038716606,0.03007635282644711,Downregulated
Feature0234,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,29.69309343658066,24.638097186235907,-5.054996250344754,0.0934573301218864,0.18474123396186845,Downregulated
Feature0230,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,12.4873409357013,9.430467291196235,-3.056873644505064,0.5464936888903468,0.5830790404478595,Downregulated
Feature0229,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,1,0,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,29.9592781107795,29.799795550890977,-0.15948255988852367,0.364264459697461,0.4021101178478466,Downregulated
Feature0223,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine-peak3,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,0,0,0,NA,NA,NA
Feature0199,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,0,16.638335904250386,16.638335904250386,3.248387726593016e-4,0.0015339608708911465,Upregulated
Feature0196,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Missing ions,0,0,0,NA,NA,NA
Feature0193,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,1.8722047271392,29.222076292850957,27.34987156571176,6.963015281645933e-10,1.775568896819713e-8,Upregulated
Feature0192,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,28.441705488122313,29.63204291430555,1.1903374261832376,2.5966886809982724e-07,2.5467523602098443e-6,Upregulated
Feature0191,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,1.7533653327702934,21.638284742647112,19.88491940987682,8.27403699516967e-7,6.59337323052583e-6,Upregulated
Feature0184,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,1,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,26.774519851852407,0,-26.774519851852407,1.2333116690098213e-30,8.803633905089901e-29,Downregulated
Feature0178,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,Missing ions,27.205518940431226,27.20241188734965,-0.003107053081574662,0.9822806356087537,0.9822806356087537,Downregulated
Feature0177,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,27.751652686514188,27.547246237727563,-0.2044064487866244,0.25022414308422697,0.3752987976126439,Downregulated
Feature0176,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,24.47110685325488,0,-24.47110685325488,2.9538812337770797e-6,1.8421227688132717e-5,Downregulated
Feature0175,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,1,0,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,3.7446617427576068,28.524313651004057,24.77965190824645,1.3194135184644098e-7,1.4632399636129347e-6,Upregulated
Feature0174,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,30.332838944907326,29.204420502682737,-1.1284184422245893,2.3580031596769074e-7,2.4051632228704454e-6,Downregulated
Feature0170,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518515,-4,Lipid,No gap,1.7092801939601467,0,-1.7092801939601467,0.33428194339465733,0.3752987976126439,Downregulated
Feature0167,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,26.164142597071432,3.551234488843764,-22.612908108227668,1.3415324710125832e-6,1.0366387276006325e-5,Downregulated
Feature0166,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,27.885430377859993,0,-27.885430377859993,8.601885397962993e-26,2.741850970600704e-24,Downregulated
Feature0165,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,31.017238606010533,30.412332834548373,-0.6049057714621604,0.013892812841898102,0.03850725298569583,Downregulated
Feature0155,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE-peak1,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,0,0,0,NA,NA,NA
Feature0152,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Adenosine-peak2,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,0,0,0,NA,NA,NA
Feature0149,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,No gap,1.8601893644987002,0,-1.8601893644987002,0.3342819433946572,0.3752987976126439,Downregulated
Feature0145,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,26.943815281815294,0,-26.943815281815294,1.1285072408315437e-30,8.803633905089901e-29,Downregulated
Feature0144,[Similar to: NP-022075; ΔMass: 142.0631 Da],C30 H32 O10,552.19968,NA,[Similar to: NP-022075; ΔMass: 142.0631 Da],30,32,0,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0138,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,28.063961262266698,13.723486323029256,-14.340474939237442,0.0023498893234614993,0.009362840273166912,Downregulated
Feature0134,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,0,1,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,27.724819823089888,26.875238471964252,-0.8495813511256358,2.0339688415556063e-5,1.234909653801618e-4,Downregulated
Feature0124,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,No gap,0,0,0,NA,NA,NA
Feature0122,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0115,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Phenol,Missing ions,27.53859499979356,27.661674327038156,0.12307932724459647,0.39690471543836037,0.4343806971535703,Upregulated
Feature0113,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,1.7863891196549466,0,-1.7863891196549466,0.33428194339465733,0.3752987976126439,Downregulated
Feature0111,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Missing ions,0,0,0,NA,NA,NA
Feature0110,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,20.97628892739252,22.41972631096806,1.4434373835755387,0.7057887959842417,0.7286483521294803,Upregulated
Feature0105,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0102,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,11.105232898060887,0,-11.105232898060887,0.008564800295910132,0.025396497404823665,Downregulated
Feature0093,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Missing ions,0,0,0,NA,NA,NA
Feature0092,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0091,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0089,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0088,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0087,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0083,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,12.21035112597862,0,-12.21035112597862,0.0035355716027490845,0.011432051353051446,Downregulated
Feature0079,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21536,Biosynthesis of secondary metabolites;Other,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",31,34,0,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0078,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak4",22,26,0,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0077,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,0,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0076,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16791,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0075,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16794,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0070,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,0,5.42359403673085,5.42359403673085,0.08228161308797559,0.1651408167354991,Upregulated
Feature0066,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Missing ions,0,0,0,NA,NA,NA
Feature0061,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0059,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,24.525359153241734,24.401707378978443,-0.12365177426329055,0.9619840659528214,0.9725055960520744,Downregulated
Feature0058,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,No gap,20.639728376339907,23.991706422166878,3.3519780458269715,0.32275791762080175,0.3752987976126439,Upregulated
Feature0057,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384617,0.15384615384615383,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,0,0,0,NA,NA,NA
Feature0050,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.761904761904762,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0049,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Missing ions,5.1705544174142535,1.8810040063037214,-3.289550411110532,0.33484006833989366,0.3752987976126439,Downregulated
Feature0044,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0042,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0036,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,No gap,29.219332925289272,4.032496450430578,-25.186836474858694,4.764258309419806e-7,4.338878103221609e-6,Downregulated
Feature0035,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,No gap,12.642824634757034,0,-12.642824634757034,0.0035393294074189145,0.011432051353051446,Downregulated
Feature0034,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Missing ions,1.90484394716326,0,-1.90484394716326,0.33428194339465733,0.3752987976126439,Downregulated
Feature0026,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0022,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,1,0,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,0,0,0,NA,NA,NA
Feature0019,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,No gap,21.778009231897254,7.767951494630465,-14.01005773726679,0.004314259294348001,0.013581927408132596,Downregulated
Feature0012,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0008,NA,C35 H63 N O3,545.48105,NA,Feature0008,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142856,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,10.427485563878234,11.06060152109035,0.6331159572121159,0.8985531000296059,0.916524162030198,Upregulated
Feature0005,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0005,3,2,4,18,2,0,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,6.8737312524955065,9.183772779712914,2.3100415272174075,0.6180568899840346,0.6432837018201177,Upregulated
Feature0002,NA,C4 H N4 O7 P3,309.90566,NA,Feature0002,4,1,4,7,0,3,0,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,No gap,8.262683476984586,10.605235820718606,2.3425523437340203,0.615853417754541,0.6432837018201177,Upregulated
Feature0001,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0001,9,8,0,17,2,2,0,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,No gap,6.653768052220373,1.7989700646968714,-4.854797987523502,0.17330543165174517,0.2851153875560969,Downregulated
Feature0363,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,28.238843560467007,27.54781807053508,-0.6910254899319277,0.012453495293077155,0.03489715713994147,Downregulated
Feature0325,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin-peak1,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,22.88857976466332,20.66920415897784,-2.219375605685478,0.5682235962267133,0.6037375709908829,Downregulated
Feature0324,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,No gap,0,10.0087381967013,10.0087381967013,0.01864769868881468,0.04779214925403513,Upregulated
Feature0275,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08488,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate-peak1",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0272,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,1,0,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,No gap,0,22.296888242451892,22.296888242451892,7.58681983969013e-7,6.2836671253681e-6,Upregulated
Feature0271,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,19.38566126000538,14.914552345640143,-4.471108914365239,0.3555264532466008,0.3941706329473183,Downregulated
Feature0242,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,19.39847557716714,5.576589816087457,-13.821885761079683,0.003423726072727186,0.011432051353051446,Downregulated
Feature0241,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,No gap,0,15.962024646949729,15.962024646949729,0.0011144424146119249,0.004736380262100681,Upregulated
Feature0239,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,29.9580426174352,29.395689517653327,-0.5623530997818733,0.01037929038716606,0.03007635282644711,Downregulated
Feature0238,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,No gap,10.17124942736814,20.356060092350994,10.184810664982853,0.03014809232338631,0.07463848099479134,Upregulated
Feature0237,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,3.8057748666325533,28.92048078408845,25.114705917455897,1.3197850652195097e-7,1.4632399636129347e-6,Upregulated
Feature0235,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Missing ions,1.8008973738845466,14.207760323065607,12.40686294918106,0.01022871297986615,0.029980710458228366,Upregulated
Feature0229,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,1,0,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,No gap,29.9592781107795,29.799795550890977,-0.15948255988852367,0.364264459697461,0.4021101178478466,Downregulated
Feature0221,Isoleucine,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine-peak1,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,0,0,0,NA,NA,NA
Feature0201,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,1,0,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,0,13.065508571766685,13.065508571766685,0.0032015658795194017,0.011398914395110937,Upregulated
Feature0198,Furan,C4 H4 O,68.02622,Other,Furan-peak2,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,6.9322811843797805,14.60392123039873,7.671640046018949,0.11200150762217816,0.2196952649511956,Upregulated
Feature0194,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,0,19.885768205572226,19.885768205572226,7.53707703377509e-5,4.2710103191392174e-4,Upregulated
Feature0192,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,28.441705488122313,29.63204291430555,1.1903374261832376,2.5966886809982724e-07,2.5467523602098443e-6,Upregulated
Feature0178,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,No gap,27.205518940431226,27.20241188734965,-0.003107053081574662,0.9822806356087537,0.9822806356087537,Downregulated
Feature0173,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,No gap,0,0,0,NA,NA,NA
Feature0171,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,No gap,0,0,0,NA,NA,NA
Feature0169,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,0,5.4765535183830005,5.4765535183830005,0.08228301407257854,0.1651408167354991,Upregulated
Feature0163,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,25.1834500915451,26.34337756463825,1.1599274730931484,0.531619696705569,0.5719958762021944,Upregulated
Feature0152,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Adenosine-peak2,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,0,0,0,NA,NA,NA
Feature0148,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Other,AC-LYS-OH,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,1.75010097195698,7.37686200346065,5.626761031503669,0.14169534533481193,0.2736266970372983,Upregulated
Feature0136,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,1,0,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,No gap,0,1.7301643697181928,1.7301643697181928,0.3355612778654228,0.3752987976126439,Upregulated
Feature0135,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,0,1,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,21.360865419438365,11.176452814246128,-10.184412605192238,0.035271990297299646,0.08648420697895587,Downregulated
Feature0134,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,0,1,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,27.724819823089888,26.875238471964252,-0.8495813511256358,2.0339688415556063e-5,1.234909653801618e-4,Downregulated
Feature0130,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,5.77652236699784,17.1579332086103,11.381410841612459,0.022812013556083147,0.05703003389020787,Upregulated
Feature0123,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,No gap,13.57110962896666,0,-13.57110962896666,0.0013163550549985489,0.0053402019632042465,Downregulated
Feature0115,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Phenol,No gap,27.53859499979356,27.661674327038156,0.12307932724459647,0.39690471543836037,0.4343806971535703,Upregulated
Feature0104,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,0,8.995485070568671,8.995485070568671,0.01865330862083215,0.04779214925403513,Upregulated
Feature0099,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Missing ions,0,3.696217522565321,3.696217522565321,0.16483865930217464,0.2736266970372983,Upregulated
Feature0098,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0097,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine-peak3,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,0,0,0,NA,NA,NA
Feature0095,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine-peak1,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,0,0,0,NA,NA,NA
Feature0055,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,0,13.473406783555458,13.473406783555458,0.0032185170056783824,0.011398914395110937,Upregulated
Feature0046,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,0,7.337729894599157,7.337729894599157,0.04009603132571817,0.08996803167232824,Upregulated
Feature0039,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Missing ions,1.8865069930959268,15.943919415514172,14.057412422418246,0.0038381044397534617,0.012233957901714158,Upregulated
Feature0324,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,0,10.0087381967013,10.0087381967013,0.01864769868881468,0.04779214925403513,Upregulated
Feature0323,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,0,22.88436968566252,22.88436968566252,7.638967877898474e-7,6.2836671253681e-6,Upregulated
Feature0316,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,0,9.500235641614992,9.500235641614992,0.018646630202804847,0.04779214925403513,Upregulated
Feature0241,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,0,15.962024646949729,15.962024646949729,0.0011144424146119249,0.004736380262100681,Upregulated
Feature0231,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,1,0,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,0,12.649417982519843,12.649417982519843,0.0031994793502899397,0.011398914395110937,Upregulated
Feature0172,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0362,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu-peak2,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,13.783829845983286,11.041466379731093,-2.7423634662521934,0.5832178577401483,0.6170447885325001,Downregulated
Feature0306,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine-peak2,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,1.7371171510341934,0,-1.7371171510341934,0.3342819433946572,0.3752987976126439,Downregulated
Feature0296,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Missing ions,3.63693735179942,0,-3.63693735179942,0.1643600249855508,0.2736266970372983,Downregulated
Feature0285,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,No gap,0,0,0,NA,NA,NA
Feature0282,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0278,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0259,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak4,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0247,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,21.79742386730998,9.619838807704564,-12.177585059605416,0.014049061389622829,0.0385216199392884,Downregulated
Feature0209,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0196,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0184,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,1,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,No gap,26.774519851852407,0,-26.774519851852407,1.2333116690098213e-30,8.803633905089901e-29,Downregulated
Feature0167,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,26.164142597071432,3.551234488843764,-22.612908108227668,1.3415324710125832e-6,1.0366387276006325e-5,Downregulated
Feature0166,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,27.885430377859993,0,-27.885430377859993,8.601885397962993e-26,2.741850970600704e-24,Downregulated
Feature0154,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0129,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Missing ions,29.491691147517013,0,-29.491691147517013,4.71918683163764e-33,1.2033926420675982e-30,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,3,0,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,11.836562609549114,16.165452096244167,4.3288894866950525,0.3706864399637454,0.40743552668428906,Upregulated
Feature0106,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Missing ions,11.035064948089966,1.9038760745354715,-9.131188873554494,0.036266520833956005,0.08807583631103601,Downregulated
Feature0100,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Missing ions,0,0,0,NA,NA,NA
Feature0037,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,0,0,0,NA,NA,NA
Feature0360,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,No gap,0,1.7277744054502642,1.7277744054502642,0.3355612778654228,0.3752987976126439,Upregulated
Feature0359,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,No gap,0,0,0,NA,NA,NA
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,0,1.7904476597552357,1.7904476597552357,0.3355612778654228,0.3752987976126439,Upregulated
Feature0338,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0329,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,17.899428272712875,0,-17.899428272712875,1.139594480407432e-4,5.603811909240681e-4,Downregulated
Feature0314,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666668,3,0,0,0.09090909090909093,0,Lipid,No gap,0,0,0,NA,NA,NA
Feature0287,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0267,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu-peak2,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,No gap,0,0,0,NA,NA,NA
Feature0256,Leu-Leu,C12 H24 N2 O3,244.17867,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0254,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,No gap,0,0,0,NA,NA,NA
Feature0251,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0240,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,No gap,28.839470547449853,0,-28.839470547449853,5.854452680440954e-26,2.1326934764463476e-24,Downregulated
Feature0228,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline-peak3,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,No gap,0,0,0,NA,NA,NA
Feature0225,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,1.7362083164019269,0,-1.7362083164019269,0.33428194339465733,0.3752987976126439,Downregulated
Feature0215,ile-his,C12 H20 N4 O3,268.15357,NA,ile-his-peak2,12,20,4,3,0,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,No gap,0,0,0,NA,NA,NA
Feature0210,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,No gap,27.330957699598873,0,-27.330957699598873,1.6256339837279771e-28,6.908944430843903e-27,Downregulated
Feature0208,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,No gap,0,1.7265407310258285,1.7265407310258285,0.33556127786542267,0.3752987976126439,Upregulated
Feature0206,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine-peak4,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0204,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Other,Glycyl-L-leucine-peak2,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0185,D-lysopine,C9 H18 N2 O4,218.12665,Other,D-lysopine-peak1,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0181,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0159,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,No gap,0,0,0,NA,NA,NA
Feature0139,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Missing ions,27.84528926712004,0,-27.84528926712004,1.3809621811905726e-30,8.803633905089901e-29,Downregulated
Feature0131,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,1,0,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,No gap,1.7978132480512532,0,-1.7978132480512532,0.33428194339465744,0.3752987976126439,Downregulated
Feature0082,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,No gap,17.736562385620147,0,-17.736562385620147,1.1394425656127321e-4,5.603811909240681e-4,Downregulated
Feature0080,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0069,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,No gap,26.000207912561926,0,-26.000207912561926,3.111687640542223e-30,1.5869606966765336e-28,Downregulated
Feature0062,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,No gap,20.0745467642306,0,-20.0745467642306,1.1398759127415502e-4,5.603811909240681e-4,Downregulated
Feature0045,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0034,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,No gap,1.90484394716326,0,-1.90484394716326,0.33428194339465733,0.3752987976126439,Downregulated
Feature0016,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09545,Metabolic pathways;ABC transporters;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",9,17,1,8,0,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,Missing ions,26.81634031773268,1.9213468425738642,-24.894993475158817,8.012897458962477e-9,9.729946914454436e-8,Downregulated
Feature0014,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,No gap,0,0,0,NA,NA,NA
Feature0012,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Phenol,Missing ions,0,0,0,NA,NA,NA
Feature0366,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,24.051229588371072,12.02324355555253,-12.027986032818543,0.0158194584093287,0.04291448823807254,Downregulated
Feature0344,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone-peak2,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,25.48518095663674,0,-25.48518095663674,1.2718140929225513e-9,1.8282987634285166e-8,Downregulated
Feature0341,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol-peak3,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,17.909989696172445,0,-17.909989696172445,1.1408309396205533e-4,5.603811909240681e-4,Downregulated
Feature0332,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,No gap,15.51038991764674,0,-15.51038991764674,4.2641422284456134e-4,0.0018779817112928266,Downregulated
Feature0320,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,26.24940106673974,0,-26.24940106673974,1.2802531357970987e-9,1.8282987634285166e-8,Downregulated
Feature0317,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,24.8594545752427,0,-24.8594545752427,1.2887468406511554e-9,1.8282987634285166e-8,Downregulated
Feature0315,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,No gap,21.08519079595132,0,-21.08519079595132,2.95710885768144e-6,1.8421227688132717e-5,Downregulated
Feature0313,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,No gap,1.9368560540252402,0,-1.9368560540252402,0.3342819433946572,0.3752987976126439,Downregulated
Feature0290,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,28.398580059777306,1.9770700742945428,-26.421509985482764,5.597426247067144e-9,7.136718465010608e-8,Downregulated
Feature0284,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,23.105679020671765,9.246346968092086,-13.85933205257968,0.003099899606009315,0.011398914395110937,Downregulated
Feature0281,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak3,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,21.382834997711985,0,-21.382834997711985,2.296853754177531e-5,1.3370292666681682e-4,Downregulated
Feature0277,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,No gap,12.5166515900576,0,-12.5166515900576,0.003538430674744589,0.011432051353051446,Downregulated
Feature0258,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak3,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,6.8799499954173005,5.4928417918933,-1.3871082035240008,0.7449397521766946,0.7659662774397465,Downregulated
Feature0246,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine-peak4,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,26.449195660396565,27.82794973680977,1.3787540764132054,0.48033301046887944,0.519003888430357,Upregulated
Feature0238,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,10.17124942736814,20.356060092350994,10.184810664982853,0.03014809232338631,0.07463848099479134,Upregulated
Feature0224,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine-peak4,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,29.097047406656145,28.746668022911443,-0.350379383744702,0.08033226205214844,0.1651408167354991,Downregulated
Feature0222,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine-peak2,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,27.898598340516493,27.58093739724072,-0.3176609432757722,0.2726013720501828,0.3752987976126439,Downregulated
Feature0218,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,No gap,21.836705222171915,0,-21.836705222171915,2.9615409817388192e-6,1.8421227688132717e-5,Downregulated
Feature0213,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Hypoxanthine-peak3,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Missing ions,14.735394482058899,0,-14.735394482058899,0.0013193440144386962,0.0053402019632042465,Downregulated
Feature0211,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine-peak1,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,20.860780151135607,0,-20.860780151135607,2.961844451817417e-6,1.8421227688132717e-5,Downregulated
Feature0207,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,No gap,12.63542164704244,0,-12.63542164704244,0.003541694340749272,0.011432051353051446,Downregulated
Feature0197,Furan,C4 H4 O,68.02622,Other,Furan-peak1,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,5.10799858838254,0,-5.10799858838254,0.082417993838711,0.1651408167354991,Downregulated
Feature0190,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.2307692307692308,-3,Protein,No gap,27.716377281955335,27.409153972633277,-0.3072233093220582,2.573028327626051e-4,0.0012379664595181942,Downregulated
Feature0186,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine-peak2,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,No gap,12.163850764738406,0,-12.163850764738406,0.0035355277016927322,0.011432051353051446,Downregulated
Feature0179,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,No gap,19.760918129410673,0,-19.760918129410673,2.3070308915058587e-5,1.3370292666681682e-4,Downregulated
Feature0164,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,25.25039265910394,0,-25.25039265910394,1.2663679945057748e-9,1.8282987634285166e-8,Downregulated
Feature0156,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE-peak2,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,27.022441149378686,26.95221011139607,-0.07023103798261587,0.5939307409927206,0.6232606541281636,Downregulated
Feature0151,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine-peak1,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,27.52834183032554,29.40100493451047,1.8726631041849302,4.112650070091905e-7,3.884169510642355e-6,Upregulated
Feature0150,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,27.729982746897306,0,-27.729982746897306,5.692464232429881e-24,1.6128648658551328e-22,Downregulated
Feature0147,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,25.363241196733966,0,-25.363241196733966,1.2726617491807777e-9,1.8282987634285166e-8,Downregulated
Feature0139,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,27.84528926712004,0,-27.84528926712004,1.3809621811905726e-30,8.803633905089901e-29,Downregulated
Feature0129,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,No gap,29.491691147517013,0,-29.491691147517013,4.71918683163764e-33,1.2033926420675982e-30,Downregulated
Feature0127,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,No gap,18.286014773085626,0,-18.286014773085626,1.1396357961872577e-4,5.603811909240681e-4,Downregulated
Feature0114,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak3",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,12.472406677343868,0,-12.472406677343868,0.003535929338612254,0.011432051353051446,Downregulated
Feature0106,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,No gap,11.035064948089966,1.9038760745354715,-9.131188873554494,0.036266520833956005,0.08807583631103601,Downregulated
Feature0103,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,26.13700751550428,0,-26.13700751550428,1.2898104712699856e-9,1.8282987634285166e-8,Downregulated
Feature0096,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine-peak2,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,10.43766470750692,7.495274769492793,-2.942389938014127,0.540056230613922,0.5786316756577736,Downregulated
Feature0071,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,10.295827312934506,0,-10.295827312934506,0.008563659450849444,0.025396497404823665,Downregulated
Feature0067,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,19.625200404968048,17.013786297481264,-2.611414107486784,0.5855876032347649,0.6170447885325001,Downregulated
Feature0056,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384617,0.15384615384615383,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,22.095503915425972,15.631059547148322,-6.4644443682776505,0.18800984118036648,0.30732377885252216,Downregulated
Feature0051,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.761904761904762,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,7.459080198295253,3.9282508552677355,-3.5308293430275177,0.41346143249848055,0.4505669456714211,Downregulated
Feature0043,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,17.57449024909532,21.190295430754063,3.615805181658743,0.4311065939066031,0.4677965167922714,Upregulated
Feature0038,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,No gap,3.51054841533986,0,-3.51054841533986,0.16446807479161316,0.2736266970372983,Downregulated
Feature0035,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,Missing ions,12.642824634757034,0,-12.642824634757034,0.0035393294074189145,0.011432051353051446,Downregulated
Feature0021,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,No gap,23.31382793988835,0,-23.31382793988835,2.9583223731942474e-6,1.8421227688132717e-5,Downregulated
Feature0018,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,No gap,15.447606178370034,0,-15.447606178370034,4.2714878139209396e-4,0.0018779817112928266,Downregulated
Feature0016,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09545,Metabolic pathways;ABC transporters;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",9,17,1,8,0,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,No gap,26.81634031773268,1.9213468425738642,-24.894993475158817,8.012897458962477e-9,9.729946914454436e-8,Downregulated
Feature0015,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Missing ions,17.645898938725974,1.9115939461488143,-15.73430499257716,4.762678634938605e-4,0.002058445850693804,Downregulated
Feature0010,NA,C16 H29 N O13,443.16395,NA,Feature0010,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,24.749938285060885,0,-24.749938285060885,1.2905638330083647e-9,1.8282987634285166e-8,Downregulated
Feature0006,NA,C18 H34 N2 O12,470.2113,NA,Feature0006,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,No gap,20.606432244242693,0,-20.606432244242693,2.9557483590563846e-6,1.8421227688132717e-5,Downregulated
Feature0004,NA,C16 H28 N2 O13,456.15919,NA,Feature0004,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,No gap,20.323334567115,0,-20.323334567115,2.9589943742547724e-6,1.8421227688132717e-5,Downregulated
Feature0336,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,No gap,10.51869457777262,0,-10.51869457777262,0.008565093242411118,0.025396497404823665,Downregulated
Feature0279,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,16.079436294548334,0,-16.079436294548334,4.2685135206233773e-4,0.0018779817112928266,Downregulated
Feature0273,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,1,0,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,No gap,17.58944033410774,0,-17.58944033410774,1.1427381148255506e-4,5.603811909240681e-4,Downregulated
Feature0176,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Missing ions,24.47110685325488,0,-24.47110685325488,2.9538812337770797e-6,1.8421227688132717e-5,Downregulated
Feature0174,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,No gap,30.332838944907326,29.204420502682737,-1.1284184422245893,2.3580031596769074e-7,2.4051632228704454e-6,Downregulated
Feature0164,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,No gap,25.25039265910394,0,-25.25039265910394,1.2663679945057748e-9,1.8282987634285166e-8,Downregulated
Feature0023,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,1,0,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,No gap,15.73985055845108,0,-15.73985055845108,4.267043141547537e-4,0.0018779817112928266,Downregulated
Feature0021,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Missing ions,23.31382793988835,0,-23.31382793988835,2.9583223731942474e-6,1.8421227688132717e-5,Downregulated
Feature0354,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,No gap,0,10.492637289205929,10.492637289205929,0.00809317889380245,0.024950215444903164,Upregulated
Feature0316,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,0,9.500235641614992,9.500235641614992,0.018646630202804847,0.04779214925403513,Upregulated
Feature0235,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,No gap,1.8008973738845466,14.207760323065607,12.40686294918106,0.01022871297986615,0.029980710458228366,Upregulated
Feature0151,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine-peak1,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,27.52834183032554,29.40100493451047,1.8726631041849302,4.112650070091905e-7,3.884169510642355e-6,Upregulated
Feature0033,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak7",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,11.136292608355893,11.136292608355893,0.018742019315307896,0.04779214925403513,Upregulated
Feature0364,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,No gap,0,0,0,NA,NA,NA
Feature0302,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0292,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Missing ions,0,0,0,NA,NA,NA
Feature0266,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu-peak1,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,No gap,0,0,0,NA,NA,NA
Feature0260,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak5,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,3.4972523343042,7.39631744773095,3.89906511342675,0.3422284653948213,0.3810840990204342,Upregulated
Feature0257,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,0,1.8220933143042213,1.8220933143042213,0.33556127786542267,0.3752987976126439,Upregulated
Feature0252,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,1.7474478075585,0,-1.7474478075585,0.33428194339465744,0.3752987976126439,Downregulated
Feature0233,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13722,NA,L-gamma-Glutamyl-L-leucine,11,20,2,5,0,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0214,ile-his,C12 H20 N4 O3,268.15358,NA,ile-his-peak1,12,20,4,3,0,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,No gap,0,0,0,NA,NA,NA
Feature0205,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine-peak3,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,1.7029754220516333,1.848614835408707,0.14563941335707375,0.9542261992027631,0.9694329912219306,Upregulated
Feature0160,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,No gap,0,0,0,NA,NA,NA
Feature0093,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0086,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0081,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0060,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,No gap,0,1.8410603646208357,1.8410603646208357,0.3355612778654228,0.3752987976126439,Upregulated
Feature0049,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,No gap,5.1705544174142535,1.8810040063037214,-3.289550411110532,0.33484006833989366,0.3752987976126439,Downregulated
Feature0019,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Missing ions,21.778009231897254,7.767951494630465,-14.01005773726679,0.004314259294348001,0.013581927408132596,Downregulated
Feature0248,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.8,1,0,-0.1,-0.04761904761904761,-1,Lipid,No gap,0,0,0,NA,NA,NA
Feature0111,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0102,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Missing ions,11.105232898060887,0,-11.105232898060887,0.008564800295910132,0.025396497404823665,Downregulated
Feature0368,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,No gap,1.7121637557409668,0,-1.7121637557409668,0.33428194339465733,0.3752987976126439,Downregulated
Feature0308,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,No gap,3.4105860537089,0,-3.4105860537089,0.16431989427489518,0.2736266970372983,Downregulated
Feature0296,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,No gap,3.63693735179942,0,-3.63693735179942,0.1643600249855508,0.2736266970372983,Downregulated
Feature0291,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,No gap,1.8043625841754534,0,-1.8043625841754534,0.3342819433946572,0.3752987976126439,Downregulated
Feature0200,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,No gap,1.8351985546922733,0,-1.8351985546922733,0.33428194339465733,0.3752987976126439,Downregulated
Feature0187,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Missing ions,1.7538192016177334,5.793520493191836,4.039701291574103,0.2670021469631142,0.3752987976126439,Upregulated
Feature0182,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,No gap,1.9912871864903865,0,-1.9912871864903865,0.33428194339465733,0.3752987976126439,Downregulated
Feature0133,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,No gap,1.8308917196457533,13.857402601313336,12.026510881667582,0.01096206198540349,0.031408155126717865,Upregulated
Feature0128,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,1,0,0,1.8235294117647056,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,No gap,3.315916179466627,0,-3.315916179466627,0.16432079695097515,0.2736266970372983,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,No gap,5.3216747971822,0,-5.3216747971822,0.08289421389076033,0.1651408167354991,Downregulated
Feature0109,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid-peak3,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,1.78128881616928,0,-1.78128881616928,0.33428194339465733,0.3752987976126439,Downregulated
Feature0072,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,No gap,1.7139036768009932,0,-1.7139036768009932,0.33428194339465755,0.3752987976126439,Downregulated
Feature0054,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,No gap,1.7080795430187534,0,-1.7080795430187534,0.33428194339465755,0.3752987976126439,Downregulated
Feature0040,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,No gap,1.7258947781457468,0,-1.7258947781457468,0.33428194339465733,0.3752987976126439,Downregulated
Feature0024,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,No gap,1.76984716047684,1.8509031082323428,0.08105594775550284,0.9749844461391524,0.9788229675806451,Upregulated
Feature0017,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,No gap,1.8966939243069334,2.0198480879610927,0.12315416365415932,0.9648781011810779,0.9725055960520744,Upregulated
Feature0015,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,No gap,17.645898938725974,1.9115939461488143,-15.73430499257716,4.762678634938605e-4,0.002058445850693804,Downregulated
Feature0009,NA,C11 H21 N O8 S,327.09887,Other,Feature0009,11,21,1,8,1,0,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,No gap,1.7515384815188866,0,-1.7515384815188866,0.33428194339465744,0.3752987976126439,Downregulated
Feature0143,[Similar to: NP-016381; ΔMass: -68.0626 Da],C22 H33 N O6,407.23081,NA,[Similar to: NP-016381; ΔMass: -68.0626 Da],22,33,1,6,0,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,No gap,0,0,0,NA,NA,NA
Feature0344,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone-peak2,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Missing ions,25.48518095663674,0,-25.48518095663674,1.2718140929225513e-9,1.8282987634285166e-8,Downregulated
Feature0305,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine-peak1,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,1.7536836943245933,0,-1.7536836943245933,0.33428194339465733,0.3752987976126439,Downregulated
Feature0365,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,No gap,0,1.934568757804543,1.934568757804543,0.33556127786542267,0.3752987976126439,Upregulated
Feature0355,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,No gap,0,5.39707889720865,5.39707889720865,0.08230805387073588,0.1651408167354991,Upregulated
Feature0345,RV0540000,C5 H12 O4,136.07356,NA,RV0540000,5,12,0,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,No gap,0,12.806419407952179,12.806419407952179,0.0032021698640264974,0.011398914395110937,Upregulated
Feature0334,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Phenol,No gap,0,1.8120162660251071,1.8120162660251071,0.3355612778654228,0.3752987976126439,Upregulated
Feature0297,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,No gap,0,1.7549351261869002,1.7549351261869002,0.3355612778654228,0.3752987976126439,Upregulated
Feature0294,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",C8 H11 N O4,185.06883,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide-peak2",8,11,1,4,0,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Phenol,No gap,0,8.8862013916205,8.8862013916205,0.018648289608223324,0.04779214925403513,Upregulated
Feature0262,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,No gap,0,1.9939280485719928,1.9939280485719928,0.3355612778654228,0.3752987976126439,Upregulated
Feature0236,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,No gap,0,1.7397232981629072,1.7397232981629072,0.33556127786542256,0.3752987976126439,Upregulated
Feature0195,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,No gap,0,2.0756723011496643,2.0756723011496643,0.3355612778654228,0.3752987976126439,Upregulated
Feature0099,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,No gap,0,3.696217522565321,3.696217522565321,0.16483865930217464,0.2736266970372983,Upregulated
Feature0068,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,0,11.514572736703,11.514572736703,0.008121050517360638,0.024950215444903164,Upregulated
Feature0064,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide-peak2",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,No gap,0,3.948949092762393,3.948949092762393,0.16484341828422036,0.2736266970372983,Upregulated
Feature0048,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,Missing ions,0,9.448920441757485,9.448920441757485,0.018646872340826067,0.04779214925403513,Upregulated
Feature0032,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak6",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,6.51531192946945,6.51531192946945,0.08271598362775762,0.1651408167354991,Upregulated
Feature0027,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,1.980131450470007,1.980131450470007,0.33556127786542267,0.3752987976126439,Upregulated
Feature0237,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Missing ions,3.8057748666325533,28.92048078408845,25.114705917455897,1.3197850652195097e-7,1.4632399636129347e-6,Upregulated
Feature0216,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0047,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518515,1,Lipid,No gap,0,0,0,NA,NA,NA
Feature0043,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,17.57449024909532,21.190295430754063,3.615805181658743,0.4311065939066031,0.4677965167922714,Upregulated
Feature0226,L-Alanyl-L-proline,C8 H14 N2 O3,186.10046,NA,L-Alanyl-L-proline-peak1,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,No gap,0,3.7470561765530928,3.7470561765530928,0.16503908120149485,0.2736266970372983,Upregulated
Feature0094,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,No gap,0,0,0,NA,NA,NA
Feature0011,NA,C11 H20 N4 O3,256.15356,NA,Feature0011,11,20,4,3,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0309,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,No gap,0,0,0,NA,NA,NA
Feature0289,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,No gap,0,0,0,NA,NA,NA
Feature0232,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,1,0,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,No gap,0,0,0,NA,NA,NA
Feature0318,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,0,0,0,NA,NA,NA
Feature0342,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,No gap,5.119147736703886,0,-5.119147736703886,0.0824275475128822,0.1651408167354991,Downregulated
Feature0219,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,1,0,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,No gap,7.064805637927633,0,-7.064805637927633,0.04057381820516764,0.08996803167232824,Downregulated
Feature0101,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,14.21772957725136,0,-14.21772957725136,0.001316574506285388,0.0053402019632042465,Downregulated
Feature0101,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Missing ions,14.21772957725136,0,-14.21772957725136,0.001316574506285388,0.0053402019632042465,Downregulated
Feature0328,Phenacetin,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin-peak4,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,0,2.217622847597207,2.217622847597207,0.3355612778654228,0.3752987976126439,Upregulated
Feature0299,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,No gap,0,3.5376364054962286,3.5376364054962286,0.16486304928759138,0.2736266970372983,Upregulated
Feature0288,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,No gap,0,3.6767575408486572,3.6767575408486572,0.16483071106188046,0.2736266970372983,Upregulated
Feature0162,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,No gap,0,2.0780049755677,2.0780049755677,0.3355612778654228,0.3752987976126439,Upregulated
Feature0157,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,No gap,0,1.934329309416143,1.934329309416143,0.3355612778654228,0.3752987976126439,Upregulated
Feature0003,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0003,11,18,3,6,1,1,0,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,No gap,0,1.7767496019174858,1.7767496019174858,0.3355612778654228,0.3752987976126439,Upregulated
Feature0330,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,No gap,0,13.427085012140928,13.427085012140928,0.003210702845661868,0.011398914395110937,Upregulated
Feature0327,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin-peak3,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,0,2.2330450281519716,2.2330450281519716,0.3355612778654228,0.3752987976126439,Upregulated
Feature0304,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,No gap,0,1.7455196504578645,1.7455196504578645,0.3355612778654228,0.3752987976126439,Upregulated
Feature0301,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,No gap,0,13.662334184553208,13.662334184553208,0.0032046641048070162,0.011398914395110937,Upregulated
Feature0283,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,0,7.652669138365928,7.652669138365928,0.04009827052262439,0.08996803167232824,Upregulated
Feature0269,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,0,13.1447681142369,13.1447681142369,0.0032033367033370286,0.011398914395110937,Upregulated
Feature0220,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,No gap,0,7.572038582219893,7.572038582219893,0.040107925605822985,0.08996803167232824,Upregulated
Feature0202,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,1,0,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,No gap,0,7.709991326190972,7.709991326190972,0.04030278901704229,0.08996803167232824,Upregulated
Feature0188,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,No gap,0,7.383412340377972,7.383412340377972,0.04010411298682876,0.08996803167232824,Upregulated
Feature0187,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,No gap,1.7538192016177334,5.793520493191836,4.039701291574103,0.2670021469631142,0.3752987976126439,Upregulated
Feature0180,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,2,0,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,No gap,0,5.383668758010043,5.383668758010043,0.08228828643137359,0.1651408167354991,Upregulated
Feature0153,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,No gap,0,7.4060686708416785,7.4060686708416785,0.04011743378068382,0.08996803167232824,Upregulated
Feature0146,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,1,0,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,No gap,0,7.510866917680121,7.510866917680121,0.04010075648669542,0.08996803167232824,Upregulated
Feature0118,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,No gap,0,5.594444708517265,5.594444708517265,0.08240006364148199,0.1651408167354991,Upregulated
Feature0063,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10553,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide-peak1",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,No gap,0,1.86551686042335,1.86551686042335,0.3355612778654228,0.3752987976126439,Upregulated
Feature0052,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,No gap,0,5.624150493135843,5.624150493135843,0.08227949051983804,0.1651408167354991,Upregulated
Feature0039,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,No gap,1.8865069930959268,15.943919415514172,14.057412422418246,0.0038381044397534617,0.012233957901714158,Upregulated
Feature0036,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,Missing ions,29.219332925289272,4.032496450430578,-25.186836474858694,4.764258309419806e-7,4.338878103221609e-6,Downregulated
Feature0030,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,8.824125634548265,8.824125634548265,0.04010174726403495,0.08996803167232824,Upregulated
Feature0161,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,No gap,0,0,0,NA,NA,NA
Feature0140,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,No gap,0,0,0,NA,NA,NA
Feature0132,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,No gap,0,0,0,NA,NA,NA
Feature0066,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,No gap,0,0,0,NA,NA,NA
Feature0025,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15224,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0361,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu-peak1,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,0,0,0,NA,NA,NA
Feature0356,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0286,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0268,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0250,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0203,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Other,Glycyl-L-leucine-peak1,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,0,0,0,NA,NA,NA
Feature0158,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,No gap,0,0,0,NA,NA,NA
Feature0100,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,No gap,0,0,0,NA,NA,NA
Feature0041,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,No gap,0,0,0,NA,NA,NA
Feature0293,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",C8 H11 N O4,185.06882,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide-peak1",8,11,1,4,0,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Phenol,No gap,0,1.7800548575341,1.7800548575341,0.3355612778654228,0.3752987976126439,Upregulated
Feature0270,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,No gap,0,1.9597566772093928,1.9597566772093928,0.33556127786542256,0.3752987976126439,Upregulated
Feature0168,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,No gap,0,1.9787822898748,1.9787822898748,0.33556127786542256,0.3752987976126439,Upregulated
Feature0121,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one-peak2",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,No gap,0,2.0180657072917643,2.0180657072917643,0.3355612778654228,0.3752987976126439,Upregulated
Feature0120,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one-peak1",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,No gap,0,1.9063609773625214,1.9063609773625214,0.3355612778654228,0.3752987976126439,Upregulated
Feature0117,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20382,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,No gap,0,5.690425851159978,5.690425851159978,0.0822816676133649,0.1651408167354991,Upregulated
Feature0116,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,No gap,0,1.8961588478865785,1.8961588478865785,0.3355612778654228,0.3752987976126439,Upregulated
Feature0020,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,No gap,0,1.763123034744807,1.763123034744807,0.33556127786542267,0.3752987976126439,Upregulated
Feature0017,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Missing ions,1.8966939243069334,2.0198480879610927,0.12315416365415932,0.9648781011810779,0.9725055960520744,Upregulated
Feature0367,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,No gap,0,1.8659769757250355,1.8659769757250355,0.33556127786542267,0.3752987976126439,Upregulated
Feature0298,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,No gap,0,3.5302507315806713,3.5302507315806713,0.16482368052601873,0.2736266970372983,Upregulated
Feature0119,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20383,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak4,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,No gap,0,3.8663219015626074,3.8663219015626074,0.16483102413391584,0.2736266970372983,Upregulated
Feature0108,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid-peak2,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,0,1.856702930889107,1.856702930889107,0.3355612778654228,0.3752987976126439,Upregulated
Feature0107,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid-peak1,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,0,3.507642037319328,3.507642037319328,0.16482424897857625,0.2736266970372983,Upregulated
Feature0053,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,1,0,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,No gap,0,1.8052948702406284,1.8052948702406284,0.3355612778654228,0.3752987976126439,Upregulated
Feature0029,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08955,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,6.340494234747129,6.340494234747129,0.08252068312239012,0.1651408167354991,Upregulated
Feature0353,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,No gap,3.38199641497174,0,-3.38199641497174,0.16431815145829867,0.2736266970372983,Downregulated
Feature0207,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Missing ions,12.63542164704244,0,-12.63542164704244,0.003541694340749272,0.011432051353051446,Downregulated
Feature0183,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,No gap,1.8181461584243666,0,-1.8181461584243666,0.33428194339465744,0.3752987976126439,Downregulated
Feature0142,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,No gap,1.78250110059172,0,-1.78250110059172,0.33428194339465733,0.3752987976126439,Downregulated
Feature0007,NA,C35 H63 N O3,545.48106,NA,Feature0007,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142856,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,1.7680644776490468,0,-1.7680644776490468,0.33428194339465733,0.3752987976126439,Downregulated
Feature0280,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,0,0,0,NA,NA,NA
Feature0085,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.137931034482759,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,No gap,0,0,0,NA,NA,NA
Feature0331,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,No gap,0,1.7737811939366714,1.7737811939366714,0.33556127786542267,0.3752987976126439,Upregulated
Feature0307,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,0,1.8445320084501071,1.8445320084501071,0.3355612778654228,0.3752987976126439,Upregulated
Feature0261,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,No gap,0,1.846351441367943,1.846351441367943,0.3355612778654228,0.3752987976126439,Upregulated
Feature0292,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,No gap,0,0,0,NA,NA,NA
Feature0062,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Missing ions,20.0745467642306,0,-20.0745467642306,1.1398759127415502e-4,5.603811909240681e-4,Downregulated
Feature0189,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,No gap,3.4905790021206733,0,-3.4905790021206733,0.16440327448486639,0.2736266970372983,Downregulated
Feature0112,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11165,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,3.5700995518841796,0,-3.5700995518841796,0.1643179973186699,0.2736266970372983,Downregulated
Feature0202,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,1,0,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Missing ions,0,7.709991326190972,7.709991326190972,0.04030278901704229,0.08996803167232824,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid-peak1,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,3.337135027807627,0,-3.337135027807627,0.1643196565881527,0.2736266970372983,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,No gap,0,3.7461474436558215,3.7461474436558215,0.16483939607867273,0.2736266970372983,Upregulated
Feature0326,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin-peak2,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,0,2.200777996617986,2.200777996617986,0.3355612778654228,0.3752987976126439,Upregulated
Feature0265,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,No gap,0,1.8803674023321928,1.8803674023321928,0.33556127786542267,0.3752987976126439,Upregulated
Feature0137,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,1,0,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,No gap,0,3.483171224334114,3.483171224334114,0.16483086562497293,0.2736266970372983,Upregulated
Feature0048,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,No gap,0,9.448920441757485,9.448920441757485,0.018646872340826067,0.04779214925403513,Upregulated
Feature0032,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak6",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Missing ions,0,6.51531192946945,6.51531192946945,0.08271598362775762,0.1651408167354991,Upregulated
Feature0013,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,No gap,0,7.461814618743029,7.461814618743029,0.04009590733951166,0.08996803167232824,Upregulated
Feature0243,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine-peak1,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,0,0,0,NA,NA,NA
Feature0264,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,No gap,0,0,0,NA,NA,NA
Feature0227,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline-peak2,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,No gap,0,0,0,NA,NA,NA
Feature0217,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Phenol,No gap,0,0,0,NA,NA,NA
Feature0319,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,1.7871321178777333,0,-1.7871321178777333,0.33428194339465733,0.3752987976126439,Downregulated
Feature0213,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Hypoxanthine-peak3,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,14.735394482058899,0,-14.735394482058899,0.0013193440144386962,0.0053402019632042465,Downregulated
Feature0084,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,No gap,1.96728644453874,0,-1.96728644453874,0.33428194339465733,0.3752987976126439,Downregulated
Feature0358,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,No gap,0,3.846757741187143,3.846757741187143,0.16504139769981513,0.2736266970372983,Upregulated
Feature0322,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,0,3.709025349386293,3.709025349386293,0.16482364321983664,0.2736266970372983,Upregulated
Feature0321,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,No gap,0,1.8717963722376714,1.8717963722376714,0.3355612778654228,0.3752987976126439,Upregulated
Feature0310,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,No gap,0,4.154351973262129,4.154351973262129,0.16482432040345757,0.2736266970372983,Upregulated
Feature0263,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,0,1.9350425811829144,1.9350425811829144,0.3355612778654228,0.3752987976126439,Upregulated
Feature0073,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,No gap,0,3.673548564950607,3.673548564950607,0.1648260497462912,0.2736266970372983,Upregulated
Feature0195,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Missing ions,0,2.0756723011496643,2.0756723011496643,0.3355612778654228,0.3752987976126439,Upregulated
Feature0031,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,4.331416849075521,4.331416849075521,0.1652490640931135,0.2736266970372983,Upregulated
Feature0253,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,No gap,0,0,0,NA,NA,NA
Feature0074,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,No gap,0,1.9825456759744287,1.9825456759744287,0.33556127786542267,0.3752987976126439,Upregulated
Feature0065,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,No gap,0,1.8225764257358072,1.8225764257358072,0.3355612778654228,0.3752987976126439,Upregulated
Feature0190,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.2307692307692308,-3,Protein,Missing ions,27.716377281955335,27.409153972633277,-0.3072233093220582,2.573028327626051e-4,0.0012379664595181942,Downregulated
Feature0141,[Similar to: NP-013538; ΔMass: 86.0004 Da],C15 H18 O11,374.08493,NA,[Similar to: NP-013538; ΔMass: 86.0004 Da],15,18,0,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Other,No gap,0,0,0,NA,NA,NA
Feature0340,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol-peak2,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,1.78874636878808,0,-1.78874636878808,0.33428194339465767,0.3752987976126439,Downregulated
Feature0244,L-Tyrosine,C9 H11 N O3,181.0739,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine-peak2,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,1.9136196706256332,0,-1.9136196706256332,0.33428194339465733,0.3752987976126439,Downregulated
Feature0212,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Hypoxanthine-peak2,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,1.80886897779582,0,-1.80886897779582,0.33428194339465733,0.3752987976126439,Downregulated
Feature0103,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Missing ions,26.13700751550428,0,-26.13700751550428,1.2898104712699856e-9,1.8282987634285166e-8,Downregulated
Feature0031,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Missing ions,0,4.331416849075521,4.331416849075521,0.1652490640931135,0.2736266970372983,Upregulated
Feature0028,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,0,2.1938938501684357,2.1938938501684357,0.3355612778654228,0.3752987976126439,Upregulated
